Premier Nigerian pharmaceutical company established in 2022 to revolutionize pharmaceutical delivery in Nigeria.
Enzapharm Limited is a premier Nigerian pharmaceutical company established in 2022 and registered with the Corporate Affairs Commission (CAC) under the Companies and Allied Matters Act of 2020.
We are strategically positioned to revolutionize pharmaceutical delivery in Nigeria through cutting-edge manufacturing capabilities, innovative product development, and an extensive distribution network designed specifically for Nigeria's evolving healthcare landscape.
With Nigeria's pharmaceutical expenditure projected to reach ₦1.2 trillion by 2028 and ongoing healthcare policy reforms, Enzapharm is positioned to capture significant market share through our innovative business model.
Quality Assurance
Local Manufacturing
Extensive Distribution
Our healthcare services division providing comprehensive medical solutions across Nigeria. Bioenza focuses on bridging the gap in healthcare accessibility through innovative service delivery models.
Our diagnostic laboratories offering state-of-the-art testing and diagnostic services. Enzalab provides accurate and timely diagnostic results to support clinical decision-making.